Bramshill Investments, LLC Abb Vie Inc. Transaction History

Bramshill Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $2,404 - $2,783	-18 Reduced 6.16%	274 $40,000
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $1.58 Million - $1.97 Million	-11,946 Reduced 97.61%	292 $39,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $24,005 - $27,645	166 Added 1.38%	12,238 $1.95 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.67 Million - $2 Million	12,072 New	12,072 $1.95 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $719,983 - $972,053	-8,945 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $10,996 - $12,906	128 Added 1.45%	8,945 $783,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $15,847 - $21,206	216 Added 2.51%	8,817 $866,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $554,764 - $841,091	8,601 New	8,601 $655,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bramshill Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Bramshill Investments, LLC with notifications on news.